金币
UID5309
帖子
主题
积分1460
注册时间2011-11-4
最后登录1970-1-1
听众
性别保密
|
发表于 2020-9-28 13:14:51
|
显示全部楼层
EMA的Guideline on manufacture of the finished dosage form里有一段话可以参考
The reasons for any prolonged storage/processing times should be stated and be consistent with GMP. Time limits for processing should be minimised and limits should be justified and appropriate to ensure product quality. As a general rule, prolonged storage means more than 30 days for solid oral dosage forms and more than 24 hours for sterile products. Where relevant, stability data to support the holding time should be provided on at least two pilot scale batches. The stability studies should be
performed at relevant temperature and humidity with regards to the expected bulk storage conditions (if relevant temperature and humidity during storage does not correspond with ICH condition, other conditions should be used) |
|